Vyome Holdings, Inc (HIND) stock
HINDNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.58−0.05 (-3.07%)
Close on Nov 13, 2026Market cap $11.09MP/E –Yield –
Vyome profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Vyome's profit margin for the twelve months ending Sep 30, 2026 was -2455.6%. For fiscal 2025 it was -3209.7%, against -563.3% the year before. The highest annual figure on record is -131.2% in fiscal 2023.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -3209.7% | −2646.4 |
| FY2024 | Dec 31, 2024 | -563.3% | −432.1 |
| FY2023 | Dec 31, 2023 | -131.2% | +279.9 |
| FY2022 | Dec 31, 2022 | -411.2% | +53.2 |
| FY2021 | Dec 31, 2021 | -464.3% | −272.9 |
| FY2020 | Dec 31, 2020 | -191.4% | +530.2 |
| FY2019 | Dec 31, 2019 | -721.6% | −310.9 |
| FY2018 | Dec 31, 2018 | -410.7% | −60.1 |
| FY2017 | Dec 31, 2017 | -350.7% | +252.5 |
| FY2016 | Dec 31, 2016 | -603.2% | −218.0 |
| FY2015 | Dec 31, 2015 | -385.2% | −105.7 |
| FY2014 | Dec 31, 2014 | -279.5% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -1526.6% | +22829.6 |
| Q2 FY2026 | Jun 30, 2026 | -2543.3% | −1925.2 |
| Q1 FY2026 | Mar 31, 2026 | -3048.1% | −2900.0 |
| Q4 FY2025 | Dec 31, 2025 | -3352.7% | −2853.7 |
| Q3 FY2025 | Sep 30, 2025 | -24356.2% | −23708.1 |
| Q2 FY2025 | Jun 30, 2025 | -618.1% | −536.9 |
| Q1 FY2025 | Mar 31, 2025 | -148.0% | −35.2 |
| Q4 FY2024 | Dec 31, 2024 | -499.1% | −413.4 |
| Q3 FY2024 | Sep 30, 2024 | -648.1% | −484.1 |
| Q2 FY2024 | Jun 30, 2024 | -81.2% | +73.8 |
| Q1 FY2024 | Mar 31, 2024 | -112.8% | +3.6 |
| Q4 FY2023 | Dec 31, 2023 | -85.7% | +443.9 |
| Q3 FY2023 | Sep 30, 2023 | -164.0% | +271.5 |
| Q2 FY2023 | Jun 30, 2023 | -155.0% | +171.6 |
| Q1 FY2023 | Mar 31, 2023 | -116.4% | +216.2 |
| Q4 FY2022 | Dec 31, 2022 | -529.5% | +656.0 |
| Q3 FY2022 | Sep 30, 2022 | -435.5% | +26.6 |
| Q2 FY2022 | Jun 30, 2022 | -326.6% | −216.4 |
| Q1 FY2022 | Mar 31, 2022 | -332.6% | −181.3 |
| Q4 FY2021 | Dec 31, 2021 | -1185.5% | −919.4 |
| Q3 FY2021 | Sep 30, 2021 | -462.1% | −318.3 |
| Q2 FY2021 | Jun 30, 2021 | -110.2% | +101.5 |
| Q1 FY2021 | Mar 31, 2021 | -151.3% | +523.2 |
| Q4 FY2020 | Dec 31, 2020 | -266.2% | +358.1 |
| Q3 FY2020 | Sep 30, 2020 | -143.8% | +969.1 |
| Q2 FY2020 | Jun 30, 2020 | -211.8% | +1541.4 |
| Q1 FY2020 | Mar 31, 2020 | -674.5% | −207.4 |
| Q4 FY2019 | Dec 31, 2019 | -624.3% | −194.2 |
| Q3 FY2019 | Sep 30, 2019 | -1112.9% | −887.1 |
| Q2 FY2019 | Jun 30, 2019 | -1753.1% | −1396.1 |
| Q1 FY2019 | Mar 31, 2019 | -467.0% | +433.8 |
| Q4 FY2018 | Dec 31, 2018 | -430.1% | −156.0 |
| Q3 FY2018 | Sep 30, 2018 | -225.8% | +103.2 |
| Q2 FY2018 | Jun 30, 2018 | -357.0% | +36.8 |
| Q1 FY2018 | Mar 31, 2018 | -900.9% | −374.7 |
| Q4 FY2017 | Dec 31, 2017 | -274.1% | +696.7 |
| Q3 FY2017 | Sep 30, 2017 | -329.0% | – |
| Q2 FY2017 | Jun 30, 2017 | -393.8% | – |
| Q1 FY2017 | Mar 31, 2017 | -526.2% | – |
| Q4 FY2016 | Dec 31, 2016 | -970.9% | – |
See a number that looks wrong?